Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population
- PMID: 15717312
- DOI: 10.1002/pros.20241
Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population
Abstract
Background: Epidemiologic studies have suggested that environmental factors and diet are important risk factors in the pathogenesis of prostate cancer. The N-acetyltransferases (NAT) are important enzymes in activation and inactivation of various carcinogens, including those found in well-cooked meat and cigarette smoke.
Methods: We analyzed DNA samples from 146 prostate cancer patients and 174 healthy men. We used PCR-RFLP method to analyze NAT 1 and NAT 2 polymorphisms.
Results: We did not find statistically significant differences in NAT 1 genotypes frequencies between prostate cancer patients and control group. We observed an association of the slow acetylator genotype, NAT 2*6/NAT2*6 with prostate cancer protection (P=0.017; OR=0.31, 95% CI 0.11--0.84). Multivariate logistic regression analysis confirmed this association (0.030; OR=0.32, 95% CI 0.12--0.89).
Conclusions: Our results indicate a role of NAT2 polymorphisms in the carcinogenic pathway of prostate cancer, specifically in a population of Southern Europe.
(c) 2005 Wiley-Liss, Inc.
Similar articles
-
Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):99-107. doi: 10.1158/1055-9965.EPI-05-0618. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16434594
-
A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer.Cancer Res. 1998 Aug 1;58(15):3307-11. Cancer Res. 1998. PMID: 9699660
-
Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population.BMC Urol. 2005 Aug 6;5:12. doi: 10.1186/1471-2490-5-12. BMC Urol. 2005. PMID: 16083506 Free PMC article.
-
Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29-42. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10667461 Review.
-
[Polymorphism of N-acetyltransferase-2 and pathogenesis of neoplastic diseases].Wiad Lek. 2005;58(3-4):212-7. Wiad Lek. 2005. PMID: 16119167 Review. Polish.
Cited by
-
NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.Int J Clin Exp Med. 2015 Jun 15;8(6):9177-91. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26309576 Free PMC article.
-
Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.Environ Health Prev Med. 2017 Oct 24;22(1):72. doi: 10.1186/s12199-017-0681-0. Environ Health Prev Med. 2017. PMID: 29165164 Free PMC article.
-
Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2.Pharmacogenet Genomics. 2007 Jan;17(1):37-45. doi: 10.1097/01.fpc.0000236325.73186.2c. Pharmacogenet Genomics. 2007. PMID: 17264801 Free PMC article.
-
Lack of association between NAT2 polymorphism and prostate cancer risk: a meta-analysis and trial sequential analysis.Oncotarget. 2017 Jul 5;8(34):57440-57450. doi: 10.18632/oncotarget.19023. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915684 Free PMC article.
-
MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking status.In Vivo. 2009 Jan-Feb;23(1):7-12. In Vivo. 2009. PMID: 19368118 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical